Hepatitis-B-Immunglobulin Behring Soluzione iniettabile

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

immunoglobulinum humanum hepatitidis B

MAH:

CSL Behring AG

ATC_code:

J06BB04

INN:

immunoglobulinum humanum hepatitidis B

pharmaceutical_form:

Soluzione iniettabile

composition:

immunoglobulinum humanum hepatitidis B min. 200 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, glycinum, natrii chloridum, aqua q.s. ad solutionem pro 1 ml.

class:

B

therapeutic_group:

Emoderivati

therapeutic_area:

Immunizzazione passiva contro l'Epatite B, a partire dalla Nascita

authorization_status:

zugelassen

authorization_date:

2004-03-01